dc.contributor.author | Engesland, André | |
dc.contributor.author | Skalko-Basnet, Natasa | |
dc.contributor.author | Flaten, Gøril Eide | |
dc.date.accessioned | 2015-02-26T10:58:10Z | |
dc.date.available | 2015-02-26T10:58:10Z | |
dc.date.issued | 2014 | |
dc.identifier.citation | Journal of Pharmaceutical Sciences 104(2014) s. 1119-1127 | en_US |
dc.identifier.cristinID | FRIDAID 1189156 | |
dc.identifier.doi | 10.1002/jps.24315 | |
dc.identifier.issn | 0022-3549 | |
dc.identifier.uri | https://hdl.handle.net/10037/7246 | |
dc.identifier.urn | URN:NBN:no-uit_munin_6833 | |
dc.language.iso | eng | en_US |
dc.publisher | John Wiley & Sons | en_US |
dc.rights.accessRights | openAccess | |
dc.subject | VDP::Medisinske Fag: 700::Basale medisinske, odontologiske og veterinærmedisinske fag: 710::Klinisk farmakologi: 739 | en_US |
dc.subject | VDP::Medical disciplines: 700::Basic medical, dental and veterinary science disciplines: 710::Clinical pharmacology: 739 | en_US |
dc.title | Phospholipid Vesicle-Based Permeation Assay and EpiSkin in Assessment of Drug Therapies Destined for Skin Administration | en_US |
dc.type | Journal article | en_US |
dc.type | Tidsskriftartikkel | en_US |
dc.type | Peer reviewed | en_US |